Medical Dosimetry
Volume 33, Issue 3 , Pages 206-214 , Autumn 2008

Influence of Pro-Qura–generated Plans on Postimplant Dosimetric Quality: A Review of a Multi-Institutional Database

Received 26 June 2007 ,Accepted 18 September 2007.

References 

  1. Merrick GS, Wallner KE, Butler WM. Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland. J. Urol. 2003;169:1643–1652
  2. Stock RG, Stone RN, Tabert A, et al. A dose-response study for I-125 prostate implants. Int. J. Radiat. Oncol. Biol. Phys. 1998;41:101–108
  3. Kollmeier MA, Stock RG, Stone N. Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: Importance of patient selection and implant quality. Int. J. Radiat. Oncol. Biol. Phys. 2003;57:645–653
  4. Potters L, Huang D, Calugaru E. Importance of implant dosimetry for patients undergoing prostate brachytherapy. Urology. 2003;62:1073–1077
  5. Merrick GS, Wallner KE, Butler WM. Minimizing prostate brachytherapy-related morbidity. Urology (Review). 2003;62:786–792
  6. Lee WR, DeGuzman AF, Bare RL, et al. Postimplant analysis of transperineal interstitial permanent prostate brachytherapy: Evidence for a learning curve in the first year at a single institution. Int. J. Radiat. Oncol. Biol. Phys. 2000;46:83–88
  7. Merrick GS, Butler WM, Wallner KE, et al. Variability of prostate brachytherapy preimplant dosimetry: A multi-institutional analysis. Brachytherapy. 2005;4:241–251
  8. Nag S, Bice W, DeWyngaert K, et al. The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int. J. Radiat. Oncol. Biol. Phys. 2000;46:221–230
  9. Merrick GS, Grimm P, Sylvester J, et al. Initial analysis of Pro-Qura, A multi-institutional database of prostate brachytherapy dosimetry. Brachytherapy. 2007;6:34–37
  10. McNeely LK, Stone NN, Presser J, et al. Influence of prostate volume on dosimetry results in real-time 125I seed implantation. Int. J. Radiat. Oncol. Biol. Phys. 2004;58:292–299
  11. Bice WS, Prestidge BR, Grimm PD, et al. Centralized multi-institutional postimplant analysis for interstitial prostate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 1998;41:921–927
  12. Lee WR, Roach M, Michalski J, et al. Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy. Int. J. Radiat. Oncol. Biol. Phys. 2002;45:457–461
  13. Han BH, Wallner KE, Merrick GS, et al. The effect of interobserver differences in post-implant prostate CT image interpretation on dosimetric parameters. Med. Phys. 2003;30:1096–1102
  14. Merrick GS, Butler WM, Dorsey AT, et al. The dependence of prostate postimplant dosimetric quality on CT volume determination. Int. J. Radiat. Oncol. Biol. Phys. 1999;44:1111–1117

PII: S0958-3947(07)00159-8

doi: 10.1016/j.meddos.2007.09.001

Medical Dosimetry
Volume 33, Issue 3 , Pages 206-214 , Autumn 2008